Rituximab is indicated for the treatment of-
- Non-Hodgkin lymphoma (NHL)
- Rheumatoid arthritis
- Chronic lymphocytic leukemia (blood cancer)
- Granulomatosis with polyangiitis
- Microscopic polyangiitis
Non-Hodgkin’s Disease (Non-Hodgkin’s Lymphoma):
- Non-Hodgkin’s lymphoma is a type of blood cancer that affects the lymph system, causing the uncontrollable growth of cancer cells in the lymph nodes. Symptoms may include lymph node swelling, abdominal pain, chest pain, cough, fever, and night sweats. Mabthera 1400mg/11.7ml Solution for Subcutaneous Injection is likely prescribed as part of the treatment for this condition.
Rheumatoid Arthritis:
- Rheumatoid arthritis is an autoimmune disease where the body’s immune system attacks its tissues, leading to joint pain and damage. Symptoms include pain, swelling, stiffness, joint deformities, and loss of joint function. Mabthera 1400mg/11.7ml Solution for Subcutaneous Injection is used in combination with methotrexate for the treatment of rheumatoid arthritis.
Chronic Lymphocytic Leukemia (CLL):
- Chronic lymphocytic leukemia is a type of cancer that originates in the bone marrow and affects the blood. It involves an increased number of lymphocytes, a type of white blood cell. Symptoms may include fever, enlarged liver, bone or joint pain, shortness of breath, weakness, and bleeding from gums, or easy bruising.
Pemphigus Vulgaris:
- Pemphigus vulgaris is a condition characterized by painful blisters on the skin and the lining of the mouth, nose, throat, and genitals. It is an autoimmune disorder where the immune system mistakenly attacks healthy cells, leading to blister formation.